185 related articles for article (PubMed ID: 35606079)
1. Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis.
Boffa MB
Atherosclerosis; 2022 May; 349():72-81. PubMed ID: 35606079
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the I4399M variant of apolipoprotein(a): implications for altered prothrombotic properties of lipoprotein(a).
Scipione CA; McAiney JT; Simard DJ; Bazzi ZA; Gemin M; Romagnuolo R; Macrae FL; Ariëns RA; Hegele RA; Auld J; Gauld JW; Boffa MB; Koschinsky ML
J Thromb Haemost; 2017 Sep; 15(9):1834-1844. PubMed ID: 28632940
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of fibrinolysis by lipoprotein(a).
Anglés-Cano E; de la Peña Díaz A; Loyau S
Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside.
Marcovina SM; Koschinsky ML
Curr Opin Lipidol; 2003 Aug; 14(4):361-6. PubMed ID: 12865733
[TBL] [Abstract][Full Text] [Related]
5. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.
Anglés-Cano E; Hervio L; Rouy D; Fournier C; Chapman JM; Laplaud M; Koschinsky ML
Chem Phys Lipids; 1994 Jan; 67-68():369-80. PubMed ID: 8187237
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent.
Knapp JP; Herrmann W
Clin Chem Lab Med; 2004; 42(9):1013-9. PubMed ID: 15497466
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis.
Caplice NM; Panetta C; Peterson TE; Kleppe LS; Mueske CS; Kostner GM; Broze GJ; Simari RD
Blood; 2001 Nov; 98(10):2980-7. PubMed ID: 11698280
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
Boffa MB; Koschinsky ML
J Lipid Res; 2016 May; 57(5):745-57. PubMed ID: 26647358
[TBL] [Abstract][Full Text] [Related]
9. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
Hervio L; Chapman MJ; Thillet J; Loyau S; Anglés-Cano E
Blood; 1993 Jul; 82(2):392-7. PubMed ID: 8329699
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo.
Biemond BJ; Friederich PW; Koschinsky ML; Levi M; Sangrar W; Xia J; Büller HR; ten Cate JW
Circulation; 1997 Sep; 96(5):1612-5. PubMed ID: 9315555
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation.
Feric NT; Boffa MB; Johnston SM; Koschinsky ML
J Thromb Haemost; 2008 Dec; 6(12):2113-20. PubMed ID: 18983515
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.
Tsurupa G; Ho-Tin-Noé B; Anglés-Cano E; Medved L
J Biol Chem; 2003 Sep; 278(39):37154-9. PubMed ID: 12853452
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
Boffa MB; Marcovina SM; Koschinsky ML
Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
[TBL] [Abstract][Full Text] [Related]
14. Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.
Kang C; Dominguez M; Loyau S; Miyata T; Durlach V; Anglés-Cano E
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1232-8. PubMed ID: 12117743
[TBL] [Abstract][Full Text] [Related]
15. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
Lu H; Bruckert J; Soria J; Li H; de Gennes JL; Legrand A; Peynet J; Soria C
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):513-6. PubMed ID: 1966796
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a), fibrin binding, and plasminogen activation.
Loscalzo J; Weinfeld M; Fless GM; Scanu AM
Arteriosclerosis; 1990; 10(2):240-5. PubMed ID: 2138452
[TBL] [Abstract][Full Text] [Related]
17. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
Rahman MN; Petrounevitch V; Jia Z; Koschinsky ML
Protein Eng; 2001 Jun; 14(6):427-38. PubMed ID: 11477223
[TBL] [Abstract][Full Text] [Related]
18. [Lipoprotein(a): a link between thrombogenesis and atherogenesis].
Vucković B; Derić M
Med Pregl; 2007; 60(1-2):37-41. PubMed ID: 17853709
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.
Rouy D; Grailhe P; Nigon F; Chapman J; Anglés-Cano E
Arterioscler Thromb; 1991; 11(3):629-38. PubMed ID: 1827591
[TBL] [Abstract][Full Text] [Related]
20. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers?
Koschinsky ML
Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):267-78. PubMed ID: 17378772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
